|
Vaccine Detail
RSV-H7 |
Vaccine Information |
- Vaccine Name: RSV-H7
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Vaccine Ontology ID: VO_0004724
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- HA
gene engineering:
- Type: Recombinant protein preparation
- Description: Plasmid DNAs used for vector construction included pSV153, containing the H7 gene of Seal/Mass/80 (H7N7) (17) (Hunt et al., 1988).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: The HA selected for expression was that of A/Seal/Mass/1/80 (H7N7) (Seal/Mass/80) (Hunt et al., 1988).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Chicken Response
- Vaccination Protocol: A P1/H7 stock which expressed 5 to 10% of the level of H7 observed in influenza virus-infected chicken embryo fibroblasts was used to immunize 1-month-old chickens (Hunt et al., 1988).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: The chickens were inoculated via the nares with 10^4 EID50 of A/Chicken/Victoria/1/85 (H7N7) influenza virus (Hunt et al., 1988).
- Efficacy: This immunization resulted in low or undetectable levels of hemagglutination-inhibiting and neutralizing antibody. Despite the low serum response, challenge with a highly pathogenic H7N7 virus revealed complete protection against lethal infection (Hunt et al., 1988).
|
References |
Hunt et al., 1988: Hunt LA, Brown DW, Robinson HL, Naeve CW, Webster RG. Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. Journal of virology. 1988; 62(8); 3014-3019. [PubMed: 2839718].
|
|